Table 4: Blood oxidative stress, lipid profiles, and IL-23 of all 30 healthy men.

Reference range Control period After 4 weeks consumption
Week 0 Week 2
Oxidative stress status
TAC (mmolTrolox/L) - 1.04 ±0.17
(0.65-1.27)		 1.01 ± 0.13
(0.72-1.18)		 1.59 ± 0.11#
(0.98-1.98)
GSH (mg/g Hb) - 32.84 ± 11.71
(15.89-68.32)		 34.82 ± 13.96
(16.32-72.11)		 43.62 ± 14.83 #
(22.28-77.08)
MDA (μmol/L) - 3.32 ± 0.30
(1.48 -4.12)		 3.11 ± 0.16
(1.51-3.35)		 2.11 ± 0.34 #
(0.75-2.32)
Lipid profiles
Triglyceride (mg/dL) 35-160 120 ± 10.5
(58-250)		 110.4 ± 55.6
(43-291)		 90.67 ± 40.73 #
(37-202)
Cholesterol (mg/dL) <200 192.8 ± 38.2
(116-286)		 189.1 ± 41.9
(114-325)		 172.07 ± 34.48 #
(110-263)
HDL (mg/dL) Male
(35-55 y)		 54.5 ± 12.2
(38-89)		 56.3 ± 12.7
(40-92)		 54.53 ± 8.92
(35-76)
Pro-inflammatory cytokine IL-23
IL-23 (pg/mL) - 45.25 ± 11.31
(23.34-76.14)		 44.01 ± 10.05
(22.09-71.45)		 39.19 ± 11.25*
(21.56-65.23)

Values are mean ± SD; range for each parameter is indicated below in parentheses. TAC = total antioxidant capacity, GSH = glutathione, MDA = malondialdehyde, HDL = high density lipoprotein, IL = interleukin. * p< 0.05 and # p < 0.01 compared to both week 0 and 2 in the control period. Data was statistical analyzed with a repeated measurement ANOVA and the Least Significant Difference (LSD) test.